Mandatory Notification of Trade of Primary Insiders

Helsinki, Finland, 27 March 2026: A close associate of Cezary Cerekwicki, a primary insider of Nordhealth AS (the "Company"), has been granted 3,850 class A shares in the Company in accordance with the Company's performance share plan. Please refer to the attached notification of trading for further details. For further information, please contact: Charles MacBain, CEO charles.macbain@nordhealth.com Alexander Cram, CFO alexander.cram@nordhealth.com This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.

About Nordhealth

Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 60,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.

Headquartered in Helsinki, Finland, Nordhealth has a solid footprint in the Nordic region and a growing presence internationally, with 400 employees working either remotely or from offices (collaboration hubs). Visit the company's website at nordhealth.com (http://www.nordhealth.com).